Top trading apps
-
Flat fee trading
- Join today & get £50 FREE trading credit
-
Award Winning
- Trade 24/7
-
Best for Share Dealing
- Award Winning Trading App
-
Best for Global Trading
- £500 in trading commissions
How to buy AstraZeneca shares
Our view: The next generation of online trading platform means you can get setup & buy AstraZeneca shares in as little as 5 minutes!
- Select a share platform - See our top platform picks
- Open your share account - To do this, you will need your bank details and national insurance number
- Fund your account - You will need to fund your a/c with a debit or credit card or bank transfer
- Search for the share using the AstraZeneca stock code - Type in the AZN stock code into the search box
- Check out the latest info and price for the selected share - Some platforms offer free research and analysis
- Buy the share - Nice and easy!
| Buy & trade over 17,000+ shares online. FX conversion fee of just 0.5%. Invest from £1 Features: Easy to use platform. Demo account. Speak to other traders. Award winning trading app. | Go to website » | |
| IG offer exclusive out of hours giving access to 70+ shares when the market is closed. 313,000+ clients worldwide. FCA Regulated. Capital at risk. Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money. | ||
| Trade UK & International shares for £6. No charge for fund trades Features: One simple customer fee of 0.25% p.a. 8,000+ investments to choose from. | Go to website » | |
| Barclays gives you the investment choice and research tools you need to grow your money. Over 300,000 people have used our award winning service, expert insights and resources to help work towards their financial goals. Voted Best Stockbroker at the Online Money Awards 2023. Capital at risk. | ||
| Invest in real stocks with 0% commission*. Over 5300 instruments… Features: XTB is one of the largest stock exchange-listed FX brokers in the world with 720,000+ customers and over 20 years of activity in the financial markets. Capital at Risk Earn 5.2% interest rate per annum on uninvested GBP | Go to website » | |
| World class trading platform: Easy to use, fully customisable, superior execution speeds, performance statistics. Applying for an account is quick and easy with a secure online form, and you could be trading within minutes. Wide range of instruments -forex, indices, commodities, shares and ETF’s. Multilingual customer support team is ready to help you - 24h hours a day from Monday to Friday. *For monthly turnover up to 100,000 EUR (then comm. 0.2%, min. 10 EUR). Capital at risk | ||
| Join today & get £50 FREE trading credit (T&Cs apply). More than 40,000 UK & international investment options Invest from £1 Features: Flat fee plan starts from £4.99 pm No trading fees when you top up monthly with the ii regular investing service. The best things in life are free trades! Get £50 worth of free trades when you open an ii Trading Account before 31 August. Capital at risk. T&Cs apply. New customers only | Go to website » | |
| Trusted by over 400,000 people. Fully FSCS protected. ADVFN Winner 2022 "Best Low Cost Stockbroker". Capital at risk. | ||
| Choice of 700 low cost ETF Funds Invest from £100 Features: No buying or selling fees. Choose either commission free DIY investing, or an actively managed portfolio (0.25% charge annually). Powerful automation. Easy diversification. ETFs costs apply SPECIAL OFFER: Get a Welcome Bonus of up to £50 when you invest at least £100 with InvestEngine (Capital at risk, Ts&Cs apply). | Go to website » | |
| The InvestEngine offers investors a low cost ETF investment platform. Build your own portfolio commission free or leave it to their experts for just 0.25%. Build your own low cost portfolio using managers such as Vanguard, iShares & Invesco. FSCS protected. Capital at risk. | ||
| Choose from over 2,000 funds From £25 per month Features: Low cost ISA. Multi-award winning ISA provider. Trade from: £1.50 Funds £5.00 Shares, ETFs, investment trusts and gilts and bonds £3.50 Frequent shares dealing charge | Go to website » | |
| Trusted by over 1.5 million people. FSCS protected. Capital at risk. Other charges may apply. No subscription required | ||
| Invest in over 6,100+ US, UK & EU stocks & ETFs commission-free Features: Start with £2 investment. Superb app design and transparent account charges. Great for beginners and experienced investors alike | Go to website » | |
| Mobile app - manage your portfolio on the move. FSCS protected. Capital at risk. | ||
| Access over 3,000 funds. UK & Overseas shares. Invest from £100 or £25 pm Features: Live share prices. Award winning services. | Go to website » | |
| Hargreaves Lansdown is the UK's No 1 platform for private investors trusted by over 1.6 million customers. Capital at risk. | ||
| Access to 70,000+ instruments, smart trading tools & market insights Investment platform for different needs and experience levels | Go to website » | |
| Saxo serve clients in 170 countries, hold 70+ bn GBP in assets under management & process 1m transactions daily. FCA regulated. Capital at risk. | ||
| Buy & trade over 3500+ UK, EU and US stocks with low 0.35% currency conversion. Features: Say goodbye to high minimums and barriers to entry. Introducing the high interest vaults offer: - Interest rate: 5.21% APY on GBP, 3.83% APY on EUR, 5.39% APY on USD - Pricing: 0.25% total fees for all deposit sizes - Minimum amount: £1, €1, $1 - Maximum amount: No limit Capital at Risk | Go to website » | |
| Multi-currency investing, your money goes even further without the constant foreign exchange fees. Deposit, hold and invest in international stock markets in EUR, GBP and USD — all under one roof. Shares have a low, transparent execution cost. Investing in your local ETFs is completely free of Lightyear fee (other fees may apply). Earn interest on uninvested cash. Access live news feeds about the stocks you own, as well as professional analyst ratings & price targets. Lightyear is now live on web and has launched earnings calls audios. Capital at Risk. We, Fair Investment Company, will be paid a referral fee if you open an account and deposit funds through some of the links on this page. This includes financial promotion. | ||
AstraZeneca Stock Price
The price of AstraZeneca stock is a crucial factor to consider when investing in the company. The stock price can fluctuate based on various factors, including the company’s financial performance, market conditions, and investor sentiment. As an investor, pay attention to the stock price to make informed buy and sell decisions.
You can find the current price of AstraZeneca stock at the top of this page or through a financial news website or brokerage platform.
The price may be quoted in pounds sterling or another currency, depending on the exchange and the brokerage.
Before you buy AstraZeneca shares, it’s essential to understand the basics of investing. When you invest in a company, you essentially buy a piece of ownership. The value of your investment will depend on the performance of the company, as well as the overall state of the market.
When you invest money in AstraZeneca, you take on some risk. There are no guarantees that you will make a profit, and you could potentially lose some or all of your investment. It’s essential to consider your financial goals and risk tolerance before investing in AstraZeneca or any other company.
About AstraZeneca
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Conducting Research Before Investing in AstraZeneca
Before buying AstraZeneca shares, you must do your homework and research the company thoroughly. Several resources are available to help you learn more about AstraZeneca’s financial performance, business prospects, and stock price. AstraZeneca can be researched in the following ways:
- Look at the company’s financial statements: AstraZeneca’s financial statements, such as its annual reports and quarterly earnings releases, can provide valuable insights into the company’s performance and prospects. You can find these documents on the AstraZeneca website or through a financial news website or brokerage platform.
- Check out analyst reports: Financial analysts and research firms often publish reports on AstraZeneca, providing their views on the company’s performance and stock price. You can find these reports through a financial news website or brokerage platform.
- Use a stock analysis tool: Many brokerages and financial websites offer tools to help you analyze AstraZeneca’s stock price and performance. These tools may include charts, graphs, and other data to help you make informed investment decisions.
It’s important to remember that no one can predict the future with certainty, and investing in AstraZeneca carries some risk. You should consider your financial goals and risk tolerance before making investment decisions.
Finding Information about AstraZeneca
AstraZeneca is a publicly traded company, so a wealth of information is available about the company’s financial performance, business prospects, and stock price.
Here are some resources you can use to learn more about AstraZeneca:
- AstraZeneca’s website is excellent for general information about the company, its products and services, and its corporate governance. You can also find the company’s annual reports and other financial documents on the website
- Financial news websites: Websites such as Bloomberg, Forbes, and CNBC often publish news and analysis on AstraZeneca and other publicly traded companies. You can find articles, reports, and other resources on these websites to help you stay informed about AstraZeneca
- Brokerage platforms: If you have a brokerage account, you can access research and analysis on AstraZeneca through the brokerage’s platform. Many brokerages offer tools and resources to help investors research and analyze stocks
It’s important to note that while these resources can be helpful, it’s always a good idea to research and make investment decisions. It would help if you did not rely solely on the information provided by AstraZeneca or any other single source.
Trading AstraZeneca Shares
If you are interested in trading AstraZeneca shares, you will need to open a broker account and place buy or sell orders through the brokerage’s platform. AstraZeneca shares will fluctuate over time based on various factors, including the company’s financial performance, market trends, and investor sentiment.
As an investor, you will need to decide when to buy and sell AstraZeneca shares based on your investment strategy and the current market conditions.
There are several factors to consider when trading AstraZeneca shares. One crucial factor is the company’s financial performance and business prospects. You may want to research AstraZeneca’s financial statements, analyst reports, and other resources to understand the company’s growth potential and risks.
Another factor to consider is the stock price. Pay attention to the price of AstraZeneca shares to determine the best time to buy or sell.
It’s essential to keep in mind that trading AstraZeneca shares carry some level of risk. You could lose money if the stock price decreases or the company’s performance deteriorates. Before trading AstraZeneca shares or other securities, you should consider your financial goals and risk tolerance carefully.
AstraZeneca’s COVID-19 Vaccine
AstraZeneca is a global biopharmaceutical company well-known for its innovative and life-saving drugs. One of the company’s most notable products is a COVID-19 vaccine developed in partnership with the University of Oxford. The UK and other countries have approved the vaccine for use in the fight against the pandemic.
As an investor, you may wonder how the COVID-19 vaccine could impact AstraZeneca’s financial performance and stock price. It’s essential to remember that the vaccine is just one of many products and services offered by AstraZeneca, and a range of factors will influence the company’s financial results.
That being said, the COVID-19 vaccine could positively impact AstraZeneca’s revenue and profits. The demand for the vaccine has been high, and AstraZeneca has signed supply agreements with governments and other organizations worldwide. However, it’s important to note that the vaccine market is highly competitive, and it needs to be clarified how long the demand for the vaccine will last.
As with any investment, it’s essential to research and carefully consider your financial goals and risk tolerance before deciding to invest in AstraZeneca or any other company.
How to Buy AstraZeneca Shares
If you have decided to invest in AstraZeneca, the next step is to purchase the shares. Here is a step-by-step guide to buying AstraZeneca shares:
- Open a brokerage account: A brokerage account allows you to buy and sell stocks. In a brokerage account, you can hold and manage your investments. Each brokerage firm has its fees, minimum deposits, and platform features. You can compare various share dealing brokers and select the one that best meets your needs.
- You need to decide how many shares you wish to buy: Before buying AstraZeneca shares, you need to decide how many shares you wish to purchase. The price of the shares will depend on the current market price and the brokerage fees. Remember that you can buy fractional shares, so you don’t have to buy a whole number of shares.
- Place an order: Once you have opened a brokerage account and decided how many shares you want to buy, you can place an order through the brokerage’s platform. Specify the ticker symbol and the number of shares you wish to buy for AstraZeneca (AZN). You will also need to specify the type of order (e.g. market order, limit order) and any other details, such as the time frame for the order.
- Monitor your investment: Once you have bought AstraZeneca shares, you will need to monitor the performance of the company and the value of your investment. Set up alerts or notifications to stay informed about developments at AstraZeneca or changes in the market. AstraZeneca shares can be sold through your brokerage account as you bought them.
Understanding AstraZeneca’s Share Price
The share price is important when deciding whether to buy or sell AstraZeneca as an investor. The share price of AstraZeneca reflects the demand for the shares and the overall performance of the company.
The share price may increase if the company is performing well and investors are optimistic about its future. Conversely, the share price may decrease if the company struggles or if market conditions are unfavourable.
There are several ways to track AstraZeneca’s share price. One way is to check the UK’s LSE (London Stock exchange), where AstraZeneca shares are traded. You can also find the share price on financial news websites or brokerage platforms.
In addition to tracking the share price, you should also pay attention to analysts’ views on AstraZeneca. Financial analysts and research firms often publish reports on the company, providing their opinions on its performance and share price. These reports can be valuable for investors looking to stay informed about AstraZeneca.
It’s important to remember that the share price of AstraZeneca is just one factor to consider when making investment decisions. It would help if you also thought about the company’s business prospects, the risks and rewards of investing in AstraZeneca, and your financial goals and risk tolerance.